Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma

Published:2012-08-25 Issue:2 Volume:159 Page:252-255
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ferreri Andrés J. M.¹,Bruno Ventre Marta¹,Donadoni Giovanni¹,Cattaneo Chiara²,Fumagalli Luca³,Foppoli Marco¹,Mappa Silvia¹,Govi Silvia¹,Nicola Massimo Di⁴,Rossi Giuseppe²,Tirelli Umberto⁵,Caligaris-Cappio Federico¹,Spina Michele⁵,Re Alessandro²

Affiliation:

1. Department of Onco-Haematology; Unit of Lymphoid Malignancies; Milan; Italy

2. Division of Haematology; Spedali Civili di Brescia; Brescia; Italy

3. Infectious Diseases Unit; San Raffaele Scientific Institute; Milan; Italy

4. Medical Oncology Unit; National Cancer Institute; Milan; Italy

5. Division of Medical Oncology A; National Cancer Institute; Aviano (PN); Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12020/fullpdf

Reference10 articles.

1. Evaluation of the addition of rituximab to CODOX-M/IVAC for burkitt's lymphoma: a retrospective analysis;Barnes;Annals of Oncology,2011

2. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia;Cortes;Cancer,2002

3. The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma;Dunleavy;Blood,2010

4. Intensive chemotherapy regimen (LMB86) for st jude stage IV AIDS-related burkitt lymphoma/leukemia: a prospective study;Galicier;Blood,2007

5. AIDS-related burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy;Lim;Journal of Clinical Oncology,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome;Annals of Hematology;2024-02-20

2. Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma;Blood Advances;2022-11-22

3. Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial;Frontiers in Immunology;2021-09-03

4. A dose‐dense short‐term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high‐risk Burkitt lymphoma or high‐grade B‐cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial;British Journal of Haematology;2020-10-21

5. Optimal drug control in a four‐dimensional HIV infection model;Optimal Control Applications and Methods;2019-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3